Volver a Agenda
SESSION 7: ePI: Where are we?
Session Chair(s)
Imane Hattami
Therapeutic Area Head and Regulatory Policy Intelligence MEAR
Abbvie Biopharmaceuticals Gmbh, Morocco
Ronnie Mundair
Regional Labelling Head - Canada and LATAM - Senior Director
Pfizer, United Kingdom
Overview: In this session, we will hear from Industry Regulatory Experts and Regulators from the MENA region on regional insights, success stories and challenges, and how the adoption of the ePI can support the overall medicines ecosystem.
Speaker(s)
Where are we in the Middle East and where is ePI 1 year on?
Ronnie Mundair
Pfizer, United Kingdom
Regional Labelling Head - Canada and LATAM - Senior Director
EFPIA IREG Survey Results: Conclusions & Recommendations
Stefano Accorsi, MBA, MSc
Chiesi Farmaceutici S.p.A., Italy
Senior Director, Global Regulatory Affairs Policy, Intelligence and Affiliates
How could Evolving Technology support Patients better and support the Industry and Regulators to offer much more when it comes to Product Information?
Bernhard Salb
Roche, Switzerland
Global Supply Chain Project Manager
How could Evolving Technology support Patients better and support the Industry and Regulators to offer much more when it comes to Product Information?
Ronnie Mundair
Pfizer, United Kingdom
Regional Labelling Head - Canada and LATAM - Senior Director
Panel Discussion with Q&A on the Basic Adoption of ePI and Digital Roadmap for ePI Adoption (with the additional participation of):
Mohammed Abdelaal
Ministry of Public Health (MOPH), Qatar, Qatar
Supervisor - Drug Registration & Pricing Section, Pharmacy & Drug Depart.
Panel Discussion with Q&A on the Basic Adoption of ePI and Digital Roadmap for ePI Adoption (with the additional participation of):
Mohammad Rabi, PharmD
Jordan Food and Drug Administration (JFDA), Jordan
IT Specialist · Drug Directorate
Panel Discussion with Q&A on the Basic Adoption of ePI and Digital Roadmap for ePI Adoption (with the additional participation of):
Rehab Mehriz
Egyptian Drug Authority (EDA), Egypt
Manager - General Administration of Pharmaceutical References & leaflets
Panel Discussion with Q&A on the Basic Adoption of ePI and Digital Roadmap for ePI Adoption (with the additional participation of):
Lynsey Flitton
AbbVie, United Kingdom
Director, Strategic Global Labeling, Europe
¿Tiene una cuenta?